Amoxicillin outperforms penicillin V in treating pediatric pneumonia, study finds

FHS
June 18, 2024
5:29 am

A recent study confirmed amoxicillin’s lower risk of treatment failure compared to penicillin V in treating pediatric pneumonia, with no difference in severe complications.

Opinion | It Shouldn’t Take Another Pandemic to Invest in Digital Health

Saldanha is chief innovation officer of a health system. The public health emergency, declared in 2020 as a result of the COVID pandemic, fostered the

August 7, 2023

Inulin gel-based oral immunotherapy is effective in suppressing food allergy responses and anaphylactic shock

A novel oral immunotherapy platform that uses formulated inulin gel combined with food allergens to orally deliver dietary antigens.

July 12, 2024

Study reveals the adverse effects of prenatal exposure to ethylene oxide on fetal development

A study led by the Barcelona Institute for Global Health (ISGlobal), a centre supported by the “la Caixa” Foundation, provides new evidence on the adverse

June 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.